Join us to experience new health care technology, see prototypes in
development and network with thought leaders and researchers who are
passionate about bringing new advances to our field. Taking place on
the Stanford University campus, this event brings together innovators, researchers, clinicians and industry experts to explore and showcase the innovative pediatric technologies being developed at Stanford Children’s Health and beyond.
> Thought leaders who will discuss resources and processes that support innovation at Stanford Children’s Health
> The new, FDA-funded, UCSF-Stanford Pediatric Device Consortium (PDC) which helps drive promising pediatric device ideas to market for patients
> A panel of pediatric health entrepreneurs discussing the meaningful use of data to improve outcomes in maternal and child health
> Biotech innovators who will highlight advances in drug development
> The UCSF-Stanford PDC’s pitch competition, where designers of pediatric innovative technologies in various stages of development, from prototype to finished product, will pitch their ideas to a panel of judges for a chance at seed funding
> A speed networking session—a unique, informal environment for attendees to meet directly with innovators, thought leaders and subject matter experts
In 2018, UCSF and Stanford University teamed up to become the UCSF-Stanford Pediatric Device Consortium, incorporating the unique innovation methodology of Stanford Biodesign, whose model for device development is renowned the world over. To date, Biodesign has launched 46 successful startup companies whose technologies have now reached over a million patients.
With our dual home base at the Bay Area’s two premier children’s hospitals and with close ties to the area’s top-ranked engineering programs, the UCSF-Stanford PDC features on-site access to world-leading clinical and technical expertise. Our innovators benefit from an unparalleled network of Silicon Valley experts in medical device product development, regulatory affairs, intellectual property, reimbursement, and commercialization.
The UCSF-Stanford PDC is funded by the U.S. Food & Drug Administraton's Office of Orphan Products Development under grant no. P50FD006424.